Adverse drug reaction: Prevalence in French public hospitals;latrogenie medicamenteuse: Estimation de sa prevalence dans les hopitaux publics Francais

Therapie

Volumn 54, Issue 1, 1999, Pages 21-27

  Imbs, J L ^a   Pouyanne, P ^b   Haramburu, F ^b   Welsch, M ^a   Decker, N ^a   Blayac, J P ^b   Begaud B ^b   Andrejak M ^b   Allain, P ^b   Bechtel, P ^b   Riche C ^b   Moulin, M ^b   Lavarenne, J ^b   Albengres, E ^b   Escousse, A ^b   Mallaret, M ^b   Caron, J ^b   Merle, L ^b   Evreux, J C ^b   Jouglard, J ^b   Netter, P ^b   Larousse, C ^b   Chichmanian, R M ^b   Kreft Jais, C ^b   Biour, M ^b   Efthymiou, M L ^b   Bavoux, F ^b   Soubrie C ^b   Vandel, B ^b   Trenque, T ^b   Allain, H ^b   Tuillez, C ^b   Ollagnier, M ^b   Montastruc, J L ^b   Autret, E ^b   more..

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b NONE

Author keywords

Adverse drug reactions; Prevalence; Prospective study; Public hospitals

Indexed keywords

ANESTHETIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT; DRUG;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; CHILD; CONFERENCE PAPER; DRUG SURVEILLANCE PROGRAM; FRANCE; GENERAL HOSPITAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HOSPITAL; SCHOOL CHILD; UNIVERSITY HOSPITAL; ARTICLE; HOSPITAL DEPARTMENT; IATROGENIC DISEASE; PREVALENCE; STATISTICS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; FRANCE; HOSPITAL DEPARTMENTS; HOSPITALS, GENERAL; HOSPITALS, PUBLIC; HUMANS; IATROGENIC DISEASE; PHARMACEUTICAL PREPARATIONS; PREVALENCE;

EID: 0032605766     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a University hospital. N Engl J Med 1981; 304: 638-642.
2. Bates DW, Spell N, Cullen DJ et al. The cost of adverse drug events in hospitalised patients. JAMA 1997; 277: 307-311.
3. Décret no 95-278 du 13 mars 1995 relatif à la pharmacovigilance et modifiant le code de la santé publique. Journal Officiel du 14 mars 1995: 3935-3938.
4. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205.
5. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-308.
6. Bonnes pratiques de Pharmacovigilance. Agence du Médicament, Saint Denis. Edition décembre 1994 et Thérapie 1995; 50: 547-555.
7. e journées de pharmacologie clinique de Giens. Evaluation de la iatrogenèse médicamenteuse évitable: méthodologie. Thérapie 1998; 53: 365-370.